| 產(chǎn)品編號(hào) | bs-0293R-Bio |
| 英文名稱 | Rabbit Anti-Rat IgG H&L, Biotin conjugated |
| 中文名稱 | 生物素標(biāo)記的兔抗大鼠IgG H&L |
| 別 名 | Rabbit Anti-Rat IgG H&L (Biotin); Immunoglobulin G; |
 |
Specific References (2) | bs-0293R-Bio has been referenced in 2 publications.
[IF=5.714] Yaru Lu. et al. JAK2 inhibitor ameliorates the progression of experimental autoimmune myasthenia gravis and balances Th17/Treg cells via regulating the JAK2/STAT3-AKT/mTOR signaling pathway. INT IMMUNOPHARMACOL. 2023 Feb;115:109693 ELISA ; Rat.
[IF=4.667] Wang et al. Caspase-1 inhibitor ameliorates experimental autoimmune myasthenia gravis by innate dendric cell IL-1-IL-17 pathway. (2015) J.Neuroinflammatio. 12:118 ELISA ; Rat.
|
| 抗體來源 | Rabbit |
| 克隆類型 | Polyclonal |
| 交叉反應(yīng) | Rat |
| 產(chǎn)品應(yīng)用 | WB=1:1000-10000,IHC-P=1:100-500,IHC-F=1:100-1000,IF=1:100-1000,ELISA=1:1000-10000
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 理論分子量 | kDa |
| 檢測分子量 | |
| 性 狀 | Liquid |
| 濃 度 | 2.0 mg/ml |
| 免 疫 原 | Native Rat IgG |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 緩 沖 液 | 10 mM TBS (pH=7.4) with 1% BSA, 0.03% Proclin300 and 50% glycerol. |
| 保存條件 | Store at -20℃ for one year. Avoid repeated freeze/thaw cycles. |
| 注意事項(xiàng) | This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. |
| 產(chǎn)品介紹 |
Immunoglobulin G (IgG), is one of the most abundant proteins in serum with normal levels between 8-17 mg/mL in adult blood. IgG is important for our defence against microorganisms and the molecules are produced by B lymphocytes as a part of our adaptive immune response. The IgG molecule has two separate functions; to bind to the pathogen that elicited the response and to recruit other cells and molecules to destroy the antigen. The variability of the IgG pool is generated by somatic recombination and the number of specificities in an individual at a given time point is estimated to be 1011 variants. |
